Danaher (NYSE:DHR) announced that it entered into a definitive agreement to acquire Aldevron for approximately $9.6 billion. Fargo, N.D.-based Aldevron, which employs approximately 600 people, manufactures high-quality plasmid DNA, mRNA and proteins to serve biotechnology and pharmaceutical customers across research, clinical and commercial applications. According to a news release, Aldevron will operate as a standalone…
Why pharmaceutical companies are warming up to predictive maintenance
The pharmaceutical industry is warming to the concept of smart manufacturing — and predictive maintenance in particular. The reason for that trend is partly financial. A single hour of downtime can potentially cost millions of dollars in lost productivity, and predictive maintenance promises to make maintenance more efficient and effective. One traditional barrier to predictive…
COVID-19 propels growth for Avantor
Chemical company Avantor (NYSE:AVTR) recently said it expects to achieve sales growth of 5.4% in its third fiscal quarter of 2020, with biopharma and healthcare businesses driving quarterly revenues of $1.6 billion. Avantor offers a range of ultra-high-purity materials to biopharma companies. This year, the company also created a COVID-19 division to support virus detection, therapy…